Age- and Ethanol Concentration-Dependent Effects of Acute Binge Drinking in the HIV-1 Transgenic Rat

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue SUPPL.1, 2013, Pages

  Sarkar, Sraboni ^a   Mao, Xin ^a   Liu, Chuang ^a   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

Blood ethanol concentration; HIV 1 Tat; Locomotor activity

Indexed keywords

ALCOHOL; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ADOLESCENT; ALCOHOL BLOOD LEVEL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE DRINKING; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LOCOMOTION; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC RAT;

AGE FACTORS; ANIMALS; BINGE DRINKING; BRAIN; ETHANOL; HIV INFECTIONS; HIV-1; LIVER; MALE; RATS; RATS, INBRED F344; RATS, TRANSGENIC; SPLEEN; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 84872485552     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2012.01860.x     Document Type: Article

References (28)

1. Acheampong E, Mukhtar M, Parveen Z, Ngoubilly N, Ahmad N, Patel C, Pomerantz RJ (2002) Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology 304:222-234.
2. Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A (2010) Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses 26:511-518.
3. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B (1992) Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 66:7159-7167.
4. CDC (2010a) Alcohol and Public Health. Vol. 2011. Center for Disease Control and Prevention, Atlanta, GA.
5. CDC (2010b) Fact Sheets: Binge Drinking. Vol. 2011. Center for Disease Control and Prevention, Atlanta, GA.
6. Chang SL, Beltran JA, Swarup S (2007a) Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J Virol 81:8406-8411.
7. Chang SL, Ocasio F, Beltran JA (2007b) Immunodeficient parameters in the HIV-1 transgenic rat model. Am J Infect Dis 3:202-207.
8. Chang SL, Patel NA, Romero AA (1995) Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration. Brain Res 679:89-98.
9. Clark DB, Lynch KG, Donovan JE, Block GD (2001) Health problems in adolescents with alcohol use disorders: self-report, liver injury, and physical examination findings and correlates. Alcohol Clin Exp Res 25:1350-1359.
10. Courtney KE, Polich J (2009) Binge drinking in young adults: data, definitions, and determinants. Psychol Bull 135:142-156.
11. Flora G, Pu H, Lee YW, Ravikumar R, Nath A, Hennig B, Toborek M (2005) Proinflammatory synergism of ethanol and HIV-1 Tat protein in brain tissue. Exp Neurol 191:2-12.
12. Haorah J, Heilman D, Diekmann C, Osna N, Donohue TM Jr, Ghorpade A, Persidsky Y (2004) Alcohol and HIV decrease proteasome and immunoproteasome function in macrophages: implications for impaired immune function during disease. Cell Immunol 229:139-148.
13. Kim YC, Kim SY, Sohn YR (2003) Effect of age increase on metabolism and toxicity of ethanol in female rats. Life Sci 74:509-519.
14. Lashomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15:14-24.
15. Lawson MA, Kelley KW, Dantzer R (2011) Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2, 3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain Behav Immun 25:1569-1575.
16. Mayne M, Holden CP, Nath A, Geiger JD (2000) Release of calcium from inositol 1, 4, 5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J Immunol 164:6538-6542.
17. Naimi TS, Brewer RD, Mokdad A, Denny C, Serdula MK, Marks JS (2003) Binge drinking among US adults. JAMA 289:70-75.
18. NIAAA (2011) Rethinking Drinking: Alcohol and Your Health. Vol. 2011. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
19. Peng J, Vigorito M, Liu X, Zhou D, Wu X, Chang SL (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218:94-101.
20. Persidsky Y, Poluektova L (2006) Immune privilege and HIV-1 persistence in the CNS. Immunol Rev 213:180-194.
21. Petry NM (1999) Alcohol use in HIV patients: what we don't know may hurt us. Int J STD AIDS 10:561-570.
22. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 98:9271-9276.
23. Siegel M, Dejong W, Naimi TS, Heeren T, Rosenbloom DL, Ross C, Ostroff J, Jernigan DH (2011) Alcohol brand preferences of underage youth: results from a pilot survey among a national sample. Subst Abus 32:191-201.
24. Teixeira C, Gomes JR, Gomes P, Maurel F, Barbault F (2011) Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug. Eur J Med Chem 46:979-992.
25. Thomas SP (2007) A dangerous new type of teenage drinking. Issues Ment Health Nurs 28:1199-1200.
26. Van der Poorten D, Kenny DT, Butler T, George J (2007) Liver disease in adolescents: a cohort study of high-risk individuals. Hepatology 46:1750-1758.
27. Vigorito M, LaShomb AL, Chang SL (2007) Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2:319-328.
28. Volberding PA, Deeks SG (2010) Antiretroviral therapy and management of HIV infection. Lancet 376:49-62.